EUVIMEDEUVIMED entdecken
Crossref

Management of diabetes mellitus–associated atherosclerosis via simvastatin-loaded novasomes

Amr Gamal Fouad, Amany Belal, Olfat Yousef Gushgari, Rowaedh Ahmed Bawaked, Fadiyah Abdullah Al Shwail, Fatma I Abo El-Ela

Naunyn-Schmiedeberg's Archives of Pharmacology · 2026

DOI: 10.1007/s00210-026-05475-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, 2026. Verfasst von Amr Gamal Fouad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Amr_g@pharm.bsu.edu.eg. Hauptthemen laut MEDLINE: Simvastatin, Atherosclerosis, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Diabetes Mellitus, Experimental. Die Arbeit nennt 48 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The impact of atherosclerosis on global healthcare systems is increasing rapidly. Understanding the complications arising from constricted and blocked arteries is essential for comprehending the full impact of atherosclerosis. Additionally, atherosclerosis is exacerbated by diabetes mellitus (DM). Simvastatin (SVS), an HMG-CoA reductase antagonist, is known to protect against DM-associated atherosclerosis due to its cardioprotective, antioxidant, and anti-inflammatory effects. However, SVS has limited efficacy due to its poor solubility, short half-life, hepatic metabolism, and low bioavailability. This study aimed to develop, evaluate, and enhance nasal SVS-loaded novasomes (SLNs) with a focus on efficacy, bioavailability, and solubility for the treatment of DM-associated atherosclerosis. The efficacy of an optimized SLN formulation was investigated in albino Wistar rats. The optimized SLN formulation demonstrated an increase in bioavailability of 8.23 times, permeation of 4.52 times, and a release of 3.88-fold. The nasal SLN was found to be superior in terms of CK-MB, LDH, HDL, LDL, cholesterol, triglycerides, glutathione, superoxide dismutase, and catalase. The effectiveness and safety of the nasal SLN were validated using histopathological and toxicity studies. These results suggest that nasal SLN delivery could be a potential treatment strategy for DM-associated atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SimvastatinAtherosclerosisHydroxymethylglutaryl-CoA Reductase InhibitorsDiabetes Mellitus, ExperimentalAnimalsRats, WistarMaleBiological AvailabilityAdministration, IntranasalRats

Stichwörter der Autor:innen

AtherosclerosisBioavailabilityDiabetes mellitusNovasomesSimvastatin

Substanzen

SimvastatinHydroxymethylglutaryl-CoA Reductase Inhibitors

Autor:innen und Institutionen

  • Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt. Amr_g@pharm.bsu.edu.eg.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Taif University, P.O. Box 11099, Taif, 21944, Saudi Arabia.
  • Public Health Department, College of Health Sciences, Saudi Electronic University, Jeddah, Saudi Arabia.
  • Public Health Department, College of Health Sciences, Saudi Electronic University, Riyadh, Saudi Arabia.
  • Department of Pharmacology, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt.

Zitieren

APA

Fouad, A. G., Belal, A., Gushgari, O. Y., Bawaked, R. A., Al Shwail, F. A., & El-Ela, F. I. A. (2026). Management of diabetes mellitus–associated atherosclerosis via simvastatin-loaded novasomes. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05475-7

Vancouver

Fouad AG, Belal A, Gushgari OY, Bawaked RA, Al Shwail FA, El-Ela FIA. Management of diabetes mellitus–associated atherosclerosis via simvastatin-loaded novasomes. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05475-7

BibTeX
@article{Fouad2026,
  author = {Fouad, Amr Gamal and Belal, Amany and Gushgari, Olfat Yousef and Bawaked, Rowaedh Ahmed and Al Shwail, Fadiyah Abdullah and El-Ela, Fatma I Abo},
  title = {Management of diabetes mellitus–associated atherosclerosis via simvastatin-loaded novasomes},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2026},
  doi = {10.1007/s00210-026-05475-7}
}
Kostenlos starten →